The global biosurgery market size was valued at USD 28.4 billion in 2025 and is projected to grow from USD 29.7 billion in 2026 to USD 41.0 billion in 2033, at a CAGR of 4.7% from 2026 to 2033. North America dominated the market, accounting for a revenue share of 41.0% in 2025. Market growth is driven by increasing adoption of minimally invasive surgical procedures, continuous advancements in surgical technologies, and the rising prevalence of chronic diseases, including cancer, cardiovascular diseases, arthritis, and other non-communicable diseases. These factors are increasing the demand for products that support effective bleeding control, tissue repair, and postoperative healing during surgical procedures.
The growing geriatric population is contributing to higher demand for surgical interventions because older adults are more susceptible to chronic diseases and age-related disorders requiring surgical treatment. Biosurgery refers to the use of biologically derived products, including hemostatic agents, surgical sealants, tissue adhesives, adhesion barriers, and soft tissue repair materials, to support surgical procedures by controlling bleeding, promoting tissue healing, and reducing postoperative complications. The rising incidence of cardiovascular diseases, trauma cases, and sports-related injuries is further supporting market growth.
According to the World Health Organization (WHO), injuries and violence account for over 4.4 million deaths annually, representing nearly 8% of all deaths worldwide. Road traffic injuries account for around one-third of all injury-related deaths. The increasing burden of trauma and emergency surgical procedures is driving demand for biosurgery products used in wound management, bleeding control, tissue repair, and surgical reconstruction.
Continuous product innovation and technological advancements are expanding the adoption of biosurgery products across multiple surgical specialties. Increasing use of surgical sealants, adhesion barriers, hemostatic agents, and tissue repair products is improving surgical efficiency and patient outcomes, particularly in minimally invasive procedures. Ongoing investment in product development and advanced surgical technologies continues to support market expansion.
▪ Canada
▪ Mexico
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
▪ Argentina
▪ Saudi Arabia
▪ UAE
▪ Kuwait
This product will be delivered within 1-3 business days.
The growing geriatric population is contributing to higher demand for surgical interventions because older adults are more susceptible to chronic diseases and age-related disorders requiring surgical treatment. Biosurgery refers to the use of biologically derived products, including hemostatic agents, surgical sealants, tissue adhesives, adhesion barriers, and soft tissue repair materials, to support surgical procedures by controlling bleeding, promoting tissue healing, and reducing postoperative complications. The rising incidence of cardiovascular diseases, trauma cases, and sports-related injuries is further supporting market growth.
According to the World Health Organization (WHO), injuries and violence account for over 4.4 million deaths annually, representing nearly 8% of all deaths worldwide. Road traffic injuries account for around one-third of all injury-related deaths. The increasing burden of trauma and emergency surgical procedures is driving demand for biosurgery products used in wound management, bleeding control, tissue repair, and surgical reconstruction.
Continuous product innovation and technological advancements are expanding the adoption of biosurgery products across multiple surgical specialties. Increasing use of surgical sealants, adhesion barriers, hemostatic agents, and tissue repair products is improving surgical efficiency and patient outcomes, particularly in minimally invasive procedures. Ongoing investment in product development and advanced surgical technologies continues to support market expansion.
Global Biosurgery Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, the analyst has segmented the biosurgery market report based on product, application, and region.Product Outlook (Revenue, USD Billion, 2021 - 2033)
- Surgical sealants
- Hemostatic agents
- Adhesion barriers
- Soft Tissue attachments
- Bone graft attachments
- Others
Application Outlook (Revenue, USD Billion, 2021 - 2033)
- General surgery
- Orthopedic surgery
- Cardiovascular surgery
- Neurological surgery
- Others
Regional Outlook (Revenue, USD Billion, 2021 - 2033)
- North America
▪ Canada
▪ Mexico
- Europe
▪ Germany
▪ France
▪ Italy
▪ Spain
▪ Denmark
▪ Sweden
▪ Norway
- Asia Pacific
▪ China
▪ India
▪ Australia
▪ South Korea
▪ Thailand
- Latin America
▪ Argentina
- Middle East & Africa
▪ Saudi Arabia
▪ UAE
▪ Kuwait
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Biosurgery Market Variables, Trends, & Scope
Chapter 4. Biosurgery Market: Product Estimates & Trend Analysis
Chapter 5. Biosurgery Market: Application Estimates & Trend Analysis
Chapter 6. Biosurgery Market: Regional Estimates & Trend Analysis
Chapter 7. Competitive Landscape
Companies Mentioned
- Sanofi
- Baxter
- INTEGRA LIFESCIENCES
- Medtronic
- B. Braun SE
- Pfizer Inc
- Stryker
- Johnson & Johnson Services, Inc
- BD
- Artivion, Inc (CryoLife, Inc.)
